April 2, 2018 / 11:04 AM / 18 days ago

BRIEF-Titan Pharmaceuticals Q4 Loss Per Share $0.17

April 2 (Reuters) - Titan Pharmaceuticals Inc:

* TITAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.17

* AT DEC 31, 2017, TITAN HAD CASH OF ABOUT $7.5 MILLION, WHICH CO BELIEVES IS SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q3 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below